insights_auto
Outlook: 58.8% bullish·5.9% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
121,35 $
0,00%
(0,00) 1D
30 қыр., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Mkt. cap
24,60 млрд
Avg. vol.
1,42 млн
Volume
1,07 мың
P/E ratio
15,46
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
Mkt. cap
24,60 млрд
Avg. vol.
1,42 млн
Volume
1,07 мың
P/E ratio
15,46
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
StockStory
·
2 сағат бұрын
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
AD HOC NEWS
·
6 сағат бұрын
Incyte stock pre-market at EUR 107.65: plus 0.51 percent
News Corp
·
15 сағат бұрын
Incyte Corp. stock outperforms competitors despite losses on the day
Zacks
·
21 сағат бұрын
INCY or TECH: Which Is the Better Value Stock Right Now?
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com